| NBTX-001 | Preclinical | Phase I | Phase II | Phase III | Market |
|---|---|---|---|---|---|
| Psychiatric | |||||
| Post-Traumatic Stress Disorder (PTSD) | (Phase 2b) | ||||
| Panic Disorder (PD) | (Phase 2b) | ||||
| Neurodegenerative | |||||
| Parkinson’s Disease* | |||||
| Autism Spectrum Disorders (ASD) | |||||
| Alzheimer’s Disease | |||||
| Obsessive-Compulsive Disorder (OCD) | |||||
| Irritable Bowel Syndrome (IBS) |
